Prostate Cancer - Results from #20

PARP inhibitor-based treatment in metastatic, castration-resistant prostate cancer (mCRPC): A systematic review and meta-analysis. January 31, 2025

Transcriptome-Wide Association Study Identified Novel Blood Tissue Gene Biomarkers for Prostate Cancer Risk. January 31, 2025

ProCUSNet: Prostate Cancer Detection on B-mode Transrectal Ultrasound Using Artificial Intelligence for Targeting During Prostate Biopsies. January 31, 2025

Androgen deprivation therapy does not increase rates for reintervention, complication, or infection in primary penile implant or artificial urinary sphincter surgery: a retrospective cohort study from the TriNetX network. January 31, 2025

The gut microbiota associated with high-Gleason prostate cancer. January 31, 2025

Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis. January 31, 2025

Firmicutes in Gut Microbiota Correlate with Blood Testosterone Levels in Elderly Men. January 31, 2025

Gut Microbiota-Derived Short-Chain Fatty Acids Promote Prostate Cancer Growth via IGF1 Signaling. January 31, 2025

Gut Microbiota Dysbiosis Accelerates Prostate Cancer Progression Through Increased LPCAT1 Expression and Enhanced DNA Repair Pathways. January 31, 2025

Prostate Artery Embolization in the Setting of Prostate Cancer: Review and Opinion. January 30, 2025

External beam radiation therapy versus radical prostatectomy for high-risk prostate cancer: protocol of the RECOVER study. January 30, 2025

Focal therapy of prostate cancer: Use of artificial intelligence to define tumour volume and predict treatment outcomes. January 30, 2025

Exercise medicine as adjunct therapy during RADIation for CAncer of the prostaTE to improve treatment efficacy - protocol for the ERADICATE study: a phase II randomised controlled trial. January 30, 2025

Clinical validation of a biopsy-based six-gene signature prognostic for aggressive prostate cancer. January 30, 2025

Treatment decision regret after precision prostatectomy: An analysis of patient-reported outcomes predicting decision regret. January 30, 2025

Clarity to Present COBRA and CLARIFY Abstracts at Two World-Leading Conferences January 29, 2025

Dosimetric comparison of CyberKnife and conventional linac prostate SBRT plans: analysis of the PACE-B Study. January 29, 2025

Prognostic factors for overall survival in castration-resistant metastatic prostate cancer treated with docetaxel (MeProCSS): results from a German real-world cohort. January 29, 2025

Trends and Disparities in Prostate Cancer Mortality in the United States (1999-2020). January 29, 2025

Comparing PSA Screening Patterns and Their Role as Predictor of Prostate Cancer Diagnosis: Analysis of a Contemporary North American Cohort. January 29, 2025

Page 2 of 1456